The activation of TIE2 and PI3K/AKT pathways independent of ligands is a common feature across all vascular malformations, including BRBN and sporadically occurring VM-causing mutations (Uebelhoer et al., 2013; Nätynki et al., 2015). This evidence concerns the gene AKT1 and vascular malformation.